Biotech Acquisition Company (BIOTU)
Chart Events
Performance Outlook
| Previous Close | 10.19 |
| Open | 10.16 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 1100 |
| Day's Range | 10.06 - 10.17 |
| 52 Week Range | 8.73 - 11.11 |
| Volume | |
| Avg. Volume | 813 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Biotech Acquisition Company Announces Liquidation
New York, New York, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Biotech Acquisition Company (the “Company”) (Nasdaq: BIOT), announced today that it will not implement the extension of the time period the Company has to complete an initial business combination as approved by its shareholders at an extraordinary general meeting of shareholders held on January 19, 2023 as a result of the investor being unable to deposit the requisite funds into the Company's trust account ("Trust Account") for the extension.
- PR Newswire
Biotech Acquisition Company Announces Plan for New Sponsor to Make Additional Contributions to Trust Account Upon Approval of Proposed Extension Amendment
Biotech Acquisition Company (NASDAQ: BIOT) (the "Company"), a publicly traded special purpose acquisition company, today announced that in connection with a proposed extension (the "Extension") of the time period the Company has to complete an initial business combination, as described in the Proxy Statement (as defined below), IREEM LLC, which has entered into an agreement to acquire the current sponsor's interest in the Company (as described in the Proxy Statement), will deposit into the Compa
- Business Wire
Blade Therapeutics to Participate in "Drug Development in Pulmonary Medicine" Panel Discussion at 2022 BTIG Biotechnology Conference
SAN FRANCISCO, August 01, 2022--Blade Therapeutics to participate in "Drug Development in Pulmonary Medicine" panel discussion on August 9 at the 2022 BTIG Biotechnology Conference
